Articles

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Hagström E, Steg PG, Szarek M, et al.

Journal: 

Circulation

First published: June 30, 2022  DOI: 10.1161/CIRCULATIONAHA.121.057807